Literature DB >> 9792101

Construction, expression, and characterization of a novel fully activated recombinant single-chain hepatitis C virus protease.

S S Taremi1, B Beyer, M Maher, N Yao, W Prosise, P C Weber, B A Malcolm.   

Abstract

Efficient proteolytic processing of essential junctions of the hepatitis C virus (HCV) polyprotein requires a heterodimeric complex of the NS3 bifunctional protease/helicase and the NS4A accessory protein. A single-chain recombinant form of the protease has been constructed in which NS4A residues 21-32 (GSVVIVGRIILS) were fused in frame to the amino terminus of the NS3 protease domain (residues 3-181) through a tetrapeptide linker. The single-chain recombinant protease has been overexpressed as a soluble protein in E. coli and purified to homogeneity by a combination of metal chelate and size-exclusion chromatography. The single-chain recombinant protease domain shows full proteolytic activity cleaving the NS5A-5B synthetic peptide substrate, DTEDVVCCSMSYTWTGK with a Km and k(cat) of 20.0 +/- 2.0 microM and 9.6 +/- 2.0 min(-1), respectively; parameters identical to those of the authentic NS3(1-631)/NS4A(1-54) protein complex generated in eukaryotic cells (Sali DL et al., 1998, Biochemistry 37:3392-3401).

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9792101      PMCID: PMC2143829          DOI: 10.1002/pro.5560071011

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  28 in total

1.  Enhancement of hepatitis C virus NS3 proteinase activity by association with NS4A-specific synthetic peptides: identification of sequence and critical residues of NS4A for the cofactor activity.

Authors:  N J Butkiewicz; M Wendel; R Zhang; R Jubin; J Pichardo; E B Smith; A M Hart; R Ingram; J Durkin; P W Mui; M G Murray; L Ramanathan; B Dasmahapatra
Journal:  Virology       Date:  1996-11-15       Impact factor: 3.616

2.  Crystal structure of the hepatitis C virus NS3 protease domain complexed with a synthetic NS4A cofactor peptide.

Authors:  J L Kim; K A Morgenstern; C Lin; T Fox; M D Dwyer; J A Landro; S P Chambers; W Markland; C A Lepre; E T O'Malley; S L Harbeson; C M Rice; M A Murcko; P R Caron; J A Thomson
Journal:  Cell       Date:  1996-10-18       Impact factor: 41.582

3.  In vitro activity of hepatitis C virus protease NS3 purified from recombinant Baculovirus-infected Sf9 cells.

Authors:  C Steinkühler; L Tomei; R De Francesco
Journal:  J Biol Chem       Date:  1996-03-15       Impact factor: 5.157

4.  The crystal structure of hepatitis C virus NS3 proteinase reveals a trypsin-like fold and a structural zinc binding site.

Authors:  R A Love; H E Parge; J A Wickersham; Z Hostomsky; N Habuka; E W Moomaw; T Adachi; Z Hostomska
Journal:  Cell       Date:  1996-10-18       Impact factor: 41.582

5.  Recombinant baculovirus-expressed NS3 proteinase of hepatitis C virus shows activity in cell-based and in vitro assays.

Authors:  H Overton; D McMillan; F Gillespie; J Mills
Journal:  J Gen Virol       Date:  1995-12       Impact factor: 3.891

6.  Analysis of NS3-mediated processing of the hepatitis C virus non-structural region in vitro.

Authors:  E D D'Souza; E O'Sullivan; E M Amphlett; D J Rowlands; D V Sangar; B E Clarke
Journal:  J Gen Virol       Date:  1994-12       Impact factor: 3.891

7.  In vivo and in vitro trans-cleavage activity of hepatitis C virus serine proteinase expressed by recombinant baculoviruses.

Authors:  T Suzuki; M Sato; S Chieda; I Shoji; T Harada; Y Yamakawa; S Watabe; Y Matsuura; T Miyamura
Journal:  J Gen Virol       Date:  1995-12       Impact factor: 3.891

Review 8.  Processing pathways of the hepatitis C virus proteins.

Authors:  V Lohmann; J O Koch; R Bartenschlager
Journal:  J Hepatol       Date:  1996       Impact factor: 25.083

9.  A central hydrophobic domain of the hepatitis C virus NS4A protein is necessary and sufficient for the activation of the NS3 protease.

Authors:  L Tomei; C Failla; R L Vitale; E Bianchi; R De Francesco
Journal:  J Gen Virol       Date:  1996-05       Impact factor: 3.891

10.  Proteolytic activity of NS3 serine proteinase of hepatitis C virus efficiently expressed in Escherichia coli.

Authors:  I Shoji; T Suzuki; S Chieda; M Sato; T Harada; T Chiba; Y Matsuura; T Miyamura
Journal:  Hepatology       Date:  1995-12       Impact factor: 17.425

View more
  36 in total

Review 1.  Perspectives for the treatment of infections with Flaviviridae.

Authors:  P Leyssen; E De Clercq; J Neyts
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

2.  A macrocyclic HCV NS3/4A protease inhibitor interacts with protease and helicase residues in the complex with its full-length target.

Authors:  Nikolaus Schiering; Allan D'Arcy; Frederic Villard; Oliver Simic; Marion Kamke; Gaby Monnet; Ulrich Hassiepen; Dmitri I Svergun; Ruth Pulfer; Jörg Eder; Prakash Raman; Ursula Bodendorf
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-12       Impact factor: 11.205

3.  Drug resistance against HCV NS3/4A inhibitors is defined by the balance of substrate recognition versus inhibitor binding.

Authors:  Keith P Romano; Akbar Ali; William E Royer; Celia A Schiffer
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-17       Impact factor: 11.205

4.  Discovery and development of telaprevir: an NS3-4A protease inhibitor for treating genotype 1 chronic hepatitis C virus.

Authors:  Ann D Kwong; Robert S Kauffman; Patricia Hurter; Peter Mueller
Journal:  Nat Biotechnol       Date:  2011-11-08       Impact factor: 54.908

5.  A drug-controllable tag for visualizing newly synthesized proteins in cells and whole animals.

Authors:  Michael Z Lin; Jeffrey S Glenn; Roger Y Tsien
Journal:  Proc Natl Acad Sci U S A       Date:  2008-05-29       Impact factor: 11.205

6.  Programmable protein circuits in living cells.

Authors:  Xiaojing J Gao; Lucy S Chong; Matthew S Kim; Michael B Elowitz
Journal:  Science       Date:  2018-09-21       Impact factor: 47.728

7.  RNA binding by the NS3 protease of the hepatitis C virus.

Authors:  Robert Vaughan; Yi Li; Baochang Fan; C T Ranjith-Kumar; C Cheng Kao
Journal:  Virus Res       Date:  2012-07-16       Impact factor: 3.303

8.  Uncoupling of Protease trans-Cleavage and Helicase Activities in Pestivirus NS3.

Authors:  Fengwei Zheng; Guoliang Lu; Ling Li; Peng Gong; Zishu Pan
Journal:  J Virol       Date:  2017-10-13       Impact factor: 5.103

9.  Extended interaction networks with HCV protease NS3-4A substrates explain the lack of adaptive capability against protease inhibitors.

Authors:  Georg Dultz; Tetsuro Shimakami; Markus Schneider; Kazuhisa Murai; Daisuke Yamane; Antoine Marion; Tobias M Zeitler; Claudia Stross; Christian Grimm; Rebecca M Richter; Katrin Bäumer; MinKyung Yi; Ricardo M Biondi; Stefan Zeuzem; Robert Tampé; Iris Antes; Christian M Lange; Christoph Welsch
Journal:  J Biol Chem       Date:  2020-08-03       Impact factor: 5.157

10.  Identification of HCV protease inhibitor resistance mutations by selection pressure-based method.

Authors:  Ping Qiu; Vincent Sanfiorenzo; Stephanie Curry; Zhuyan Guo; Shaotang Liu; Angela Skelton; Ellen Xia; Constance Cullen; Robert Ralston; Jonathan Greene; Xiao Tong
Journal:  Nucleic Acids Res       Date:  2009-04-24       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.